EGLN1 and neoplasm: In this study, we demonstrated that the suppressive effect of PHD2 on NSCLC is entirely dependent on its enzymatic activity, as enzymatic deficiency of PHD2 completely abolished the inhibition of PHD2 on tumor proliferation and metabolism, as well as the induction of ROS levels.